Načítá se...
GLP-1 Receptor Agonists and Cardiovascular Disease in Patients with Type 2 Diabetes
Diabetes mellitus is a chronic disease prevalence of which is high and continually growing. Cardiovascular disease continues to be the leading cause of death in patients with T2DM. The prevention of cardiovascular complications and the cardiovascular safety of treatments should be a primary objectiv...
Uloženo v:
| Vydáno v: | J Diabetes Res |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Hindawi
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5902002/ https://ncbi.nlm.nih.gov/pubmed/29805980 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/4020492 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|